Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhu, D. M.
Right arrow Articles by Uckun, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhu, D. M.
Right arrow Articles by Uckun, F. M.

Clinical Cancer Research, Vol 4, Issue 12 2967-2976, Copyright © 1998 by American Association for Cancer Research


ARTICLES

Calphostin C triggers calcium-dependent apoptosis in human acute lymphoblastic leukemia cells

DM Zhu, RK Narla, WH Fang, NC Chia and FM Uckun
Department of Immunology, Parker Hughes Cancer Center, Roseville, Minnesota 55113, USA.

Recent studies have demonstrated that the naturally occurring perylenequinone antibiotic calphostin C is a potent inhibitor of protein kinase C and can induce apoptosis in some tumor cell lines by an as yet unknown mechanism. Here we demonstrate that calphostin C induces dose-dependent apoptosis in DT40 chicken lymphoma B-cells, and targeted disruption of lyn, syk, btk, PLCgamma2, or IP3R genes does not prevent or attenuate its cytotoxicity. In our study, calphostin C also induced rapid apoptosis in human acute lymphoblastic leukemia (ALL) cell lines ALL-1 (BCR-ABL+ pre-pre-B ALL), RS4;11 (MLL-AF4+ pro-B ALL), NALM-6 (pre-B ALL), DAUDI (Burkitt's/B-cell ALL), MOLT-3 (T-ALL), and JURKAT (T-ALL), whereas other potent PKC inhibitors did not. In biochemical studies, calphostin C was discovered to induce rapid calcium mobilization from intracellular stores of ALL cell lines, and its cytotoxicity against ALL cell lines was well correlated with the magnitude of this calcium signal. Calphostin C-induced apoptosis was markedly suppressed by BAPTA/AM, a cell-permeable Ca2+ chelator as well as NiCl2, an inhibitor of Ca2+/Mg2+-dependent endonucleases. Inhibition of the Ca2+/calmodulin-dependent phosphatase calcineurin with perfluoreperazine dimadeate (a calmodulin antagonist) or cyclosporin A (a specific inhibitor of calcineurin) also reduced the magnitude of calphostin C-induced apoptosis in ALL cell lines. Calphostin C was capable of inducing calcium mobilization and apoptosis in freshly obtained primary leukemic cells from children with ALL. Taken together, our results provide unprecedented evidence that calphostin C triggers a Ca2+-dependent apoptotic signal in human ALL cells.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
X.-L. Zheng, Y. Gui, G. Du, M. A. Frohman, and D.-Q. Peng
Calphostin-C Induction of Vascular Smooth Muscle Cell Apoptosis Proceeds through Phospholipase D and Microtubule Inhibition
J. Biol. Chem., February 20, 2004; 279(8): 7112 - 7118.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
Z.-y. Wang
Ham-Wasserman Lecture: Treatment of Acute Leukemia by Inducing Differentiation and Apoptosis
Hematology, January 1, 2003; 2003(1): 1 - 13.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. E. Hawkins, D. Das, B. Young, and S. E. Moss
DT40 cells lacking the Ca2+-binding protein annexin 5 are resistant to Ca2+-dependent apoptosis
PNAS, June 11, 2002; 99(12): 8054 - 8059.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. K. Narla, C.-L. Chen, Y. Dong, and F. M. Uckun
In Vivo Antitumor Activity of Bis(4,7-dimethyl-1,10-phenanthroline) Sulfatooxovanadium(IV) {METVAN [VO(SO4)(Me2-Phen)2]}
Clin. Cancer Res., July 1, 2001; 7(7): 2124 - 2133.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Villalba, P. Bushway, and A. Altman
Protein Kinase C-{{theta}} Mediates a Selective T Cell Survival Signal Via Phosphorylation of BAD
J. Immunol., May 15, 2001; 166(10): 5955 - 5963.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D.-M. Zhu and F. M. Uckun
Calpain Inhibitor II Induces Caspase-dependent Apoptosis in Human Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma Cells as Well as Some Solid Tumor Cells
Clin. Cancer Res., June 1, 2000; 6(6): 2456 - 2463.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
R. K. Narla, Y. Dong, O. J. D’Cruz, C. Navara, and F. M. Uckun
Bis(4,7-dimethyl-1,10-phenanthroline) Sulfatooxovanadium(IV) as a Novel Apoptosis-inducing Anticancer Agent
Clin. Cancer Res., April 1, 2000; 6(4): 1546 - 1556.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. Malaviya, D. Zhu, I. Dibirdik, and F. M. Uckun
Targeting Janus Kinase 3 in Mast Cells Prevents Immediate Hypersensitivity Reactions and Anaphylaxis
J. Biol. Chem., September 17, 1999; 274(38): 27028 - 27038.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. A. Sudbeck, X.-P. Liu, R. K. Narla, S. Mahajan, S. Ghosh, C. Mao, and F. M. Uckun
Structure-based Design of Specific Inhibitors of Janus Kinase 3 as Apoptosis-inducing Antileukemic Agents
Clin. Cancer Res., June 1, 1999; 5(6): 1569 - 1582.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D.-M. Zhu, W.-H. Fang, R. K. Narla, and F. M. Uckun
A Requirement for Protein Kinase C Inhibition for Calcium-triggered Apoptosis in Acute Lymphoblastic Leukemia Cells
Clin. Cancer Res., February 1, 1999; 5(2): 355 - 360.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. S. Hebert, A. Daviau, G. Grondin, M. Latreille, R. A. Aubin, and R. Blouin
The Mixed Lineage Kinase DLK Is Oligomerized by Tissue Transglutaminase during Apoptosis
J. Biol. Chem., October 13, 2000; 275(42): 32482 - 32490.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.